These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6220630)

  • 1. Human brain distribution of neurotensin in normals, schizophrenics, and Huntington's choreics.
    Manberg PJ; Nemeroff CB; Iversen LL; Rosser MN; Kizer JS; Prange AJ
    Ann N Y Acad Sci; 1982; 400():354-67. PubMed ID: 6220630
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
    Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A
    Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides in CSF and post-mortem brain tissue of normal controls, schizophrenics and Huntington's choreics.
    Manberg PJ; Nemeroff CB; Bissette G; Widerlov E; Youngblood WW; Kizer JS; Prange AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):97-108. PubMed ID: 2859637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study.
    Zech M; Roberts GW; Bogerts B; Crow TJ; Polak JM
    Acta Neuropathol; 1986; 71(3-4):259-66. PubMed ID: 2948368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
    Nemeroff CB; Levant B; Myers B; Bissette G
    Ann N Y Acad Sci; 1992; 668():146-56. PubMed ID: 1361110
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.
    Bird ED; Spokes EG; Iversen LL
    Acta Psychiatr Scand Suppl; 1980; 280():63-73. PubMed ID: 6447433
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease.
    Emson PC; Fahrenkrug J; Spokes EG
    Brain Res; 1979 Sep; 173(1):174-8. PubMed ID: 158404
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and autoradiographic distribution of neurotensin binding sites in the human brain.
    Sarrieau A; Javoy-Agid F; Kitabgi P; Dussaillant M; Vial M; Vincent JP; Agid Y; Rostène WH
    Brain Res; 1985 Dec; 348(2):375-80. PubMed ID: 4075096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides, the limbic lobe and schizophrenia.
    Roberts GW; Ferrier IN; Lee Y; Crow TJ; Johnstone EC; Owens DG; Bacarese-Hamilton AJ; McGregor G; O'Shaughnessey D; Polak JM
    Brain Res; 1983 Dec; 288(1-2):199-211. PubMed ID: 6198024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced density of striatal somatostatin receptors in Huntington's chorea.
    Palacios JM; Rigo M; Chinaglia G; Probst A
    Brain Res; 1990 Jul; 522(2):342-6. PubMed ID: 1977497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.
    Lahti RA; Cochrane EV; Roberts RC; Conley RR; Tamminga CA
    J Neural Transm (Vienna); 1998; 105(4-5):507-16. PubMed ID: 9720978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin in human brain: regional distribution and effects of neurological illness.
    Emson PC; Horsfield PM; Goedert M; Rossor MN; Hawkes CH
    Brain Res; 1985 Nov; 347(2):239-44. PubMed ID: 2933123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients.
    Perry TL; Kish SJ; Buchanan J; Hansen S
    Lancet; 1979 Feb; 1(8110):237-9. PubMed ID: 84898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic-based differences in neurotensin levels and receptors in brains of LS x SS mice.
    Erwin VG; Radcliffe R; Hinkle B; Jones BC
    Peptides; 1993; 14(4):821-8. PubMed ID: 8234031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study.
    Zech M; Bogerts B
    Acta Neuropathol; 1985; 68(1):32-8. PubMed ID: 2413707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesolimbic expression of neurotensin and neurotensin receptor during stress-induced gastric mucosal injury.
    Xing L; Karinch AM; Kauffman GL
    Am J Physiol; 1998 Jan; 274(1):R38-45. PubMed ID: 9458896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of neurotensin and its receptor in the central nervous system.
    Uhl GR
    Ann N Y Acad Sci; 1982; 400():132-49. PubMed ID: 6301323
    [No Abstract]   [Full Text] [Related]  

  • 19. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease.
    Ellison DW; Beal MF; Martin JB
    Brain Res; 1987 Aug; 417(2):389-92. PubMed ID: 2958109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.